Keywords: patent, challenge, zantac, uk, generics, subsidiary, amerpharm

Patent Challenge For Zantac In UK

Article | 06 March 1995

Print This

Generics (UK), a subsidiary of Amerpharm, has begun proceedings in the UK against Glaxo over the validity of its patent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in